PubMed

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.

Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, Handelsman Y, Horton ES, Lebovitz H, Levy P, Moghissi ES, Schwartz SS.

Endocr Pract. 2009 Sep-Oct;15(6):540-59.PMID: 19858063 [PubMed - in process]Related articlesFree article

Glycaemic control and vascular complications in type 2 diabetes: new observations and clinical significance.

Lebovitz HE.

J Indian Med Assoc. 2008 Nov;106(11):724-6.PMID: 19368098 [PubMed - indexed for MEDLINE]Related articles

Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Garber AJ, Handelsman Y, Einhorn D, Bergman DA, Bloomgarden ZT, Fonseca V, Garvey WT, Gavin JR 3rd, Grunberger G, Horton ES, Jellinger PS, Jones KL, Lebovitz H, Levy P, McGuire DK, Moghissi ES, Nesto RW.

Endocr Pract. 2008 Oct;14(7):933-46. No abstract available. PMID: 18996826 [PubMed - indexed for MEDLINE]Related articles

New treatments of diabetes: the beta-amylin agonists.

Lebovitz HE.

Ann Endocrinol (Paris). 2008 Apr;69(2):147-50. Epub 2008 Apr 18. Review. No abstract available. PMID: 18423421 [PubMed - indexed for MEDLINE]Related articles

Long-term changes in weight and plasma lipids during maintenance treatment with ziprasidone.

Weiden PJ, Newcomer JW, Loebel AD, Yang R, Lebovitz HE.

Neuropsychopharmacology. 2008 Apr;33(5):985-94. Epub 2007 Jul 18.PMID: 17637612 [PubMed - indexed for MEDLINE]Related articlesFree article

Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force.

Jellinger PS, Davidson JA, Blonde L, Einhorn D, Grunberger G, Handelsman Y, Hellman R, Lebovitz H, Levy P, Roberts VL; ACE/AACE Diabetes Road Map Task Force.

Endocr Pract. 2007 May-Jun;13(3):260-8. No abstract available. PMID: 17599857 [PubMed - indexed for MEDLINE]Related articles

Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes: response to Nathan et al.

Jellinger PS, Lebovitz HE, Davidson JA; ACE/AACE Outpatient Glycemic Control Implementation Task Force.

Diabetes Care. 2007 Apr;30(4):e16-7; author reply e18-20, e21-2. No abstract available. PMID: 17392531 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin resistance--a common link between type 2 diabetes and cardiovascular disease.

Lebovitz HE.

Diabetes Obes Metab. 2006 May;8(3):237-49. Review.PMID: 16634983 [PubMed - indexed for MEDLINE]Related articles

Therapeutic options in development for management of diabetes: pharmacologic agents and new technologies.

Lebovitz HE.

Endocr Pract. 2006 Jan-Feb;12 Suppl 1:142-7. Review.PMID: 16627399 [PubMed - indexed for MEDLINE]Related articles

ACE/AACE consensus conference on the implementation of outpatient management of diabetes mellitus: consensus conference recommendations.

Lebovitz HE, Austin MM, Blonde L, Davidson JA, Del Prato S, Gavin JR 3rd, Handelsman Y, Jellinger PS, Levy P, Riddle MC, Roberts VL, Siminerio LM; ACE/AACE Diabetes Recommendations Implementation Writing Committee.

Endocr Pract. 2006 Jan-Feb;12 Suppl 1:6-12. No abstract available. PMID: 16627372 [PubMed - indexed for MEDLINE]Related articles

Diabetes: assessing the pipeline.

Lebovitz H.

Atheroscler Suppl. 2006 Apr;7(1):43-9. Epub 2006 Feb 28. Review.PMID: 16504599 [PubMed - indexed for MEDLINE]Related articles

Point: visceral adiposity is causally related to insulin resistance.

Lebovitz HE, Banerji MA.

Diabetes Care. 2005 Sep;28(9):2322-5. Review. No abstract available. PMID: 16123512 [PubMed - indexed for MEDLINE]Related articlesFree article

Oral antidiabetic agents: 2004.

Lebovitz HE.

Med Clin North Am. 2004 Jul;88(4):847-63, ix-x. Review.PMID: 15308382 [PubMed - indexed for MEDLINE]Related articles

Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.

Casey DE, Haupt DW, Newcomer JW, Henderson DC, Sernyak MJ, Davidson M, Lindenmayer JP, Manoukian SV, Banerji MA, Lebovitz HE, Hennekens CH.

J Clin Psychiatry. 2004;65 Suppl 7:4-18; quiz 19-20. Review. No abstract available. PMID: 15151456 [PubMed - indexed for MEDLINE]Related articles

Treatment of insulin resistance in diabetes mellitus.

Lebovitz HE, Banerji MA.

Eur J Pharmacol. 2004 Apr 19;490(1-3):135-46. Review.PMID: 15094080 [PubMed - indexed for MEDLINE]Related articles

Follow-up report on the diagnosis of diabetes mellitus.

Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Diabetes Care. 2003 Nov;26(11):3160-7. Review. No abstract available. PMID: 14578255 [PubMed - indexed for MEDLINE]Related articlesFree article

Metabolic consequences of atypical antipsychotic drugs.

Lebovitz HE.

Psychiatr Q. 2003 Fall;74(3):277-90. Review.PMID: 12918602 [PubMed - indexed for MEDLINE]Related articles

The relationship of obesity to the metabolic syndrome.

Lebovitz HE.

Int J Clin Pract Suppl. 2003 Mar;(134):18-27. Review.PMID: 12793594 [PubMed - indexed for MEDLINE]Related articles

Implications of the United kingdom prospective diabetes study.

Genuth S, Eastman R, Kahn R, Klein R, Lachin J, Lebovitz H, Nathan D, Vinicor F; American Diabetes Association.

Diabetes Care. 2003 Jan;26 Suppl 1:S28-32. No abstract available. PMID: 12502617 [PubMed - indexed for MEDLINE]Related articlesFree article

Treating hyperglycemia in type 2 diabetes: new goals and strategies.

Lebovitz HE.

Cleve Clin J Med. 2002 Oct;69(10):809-20. Review.PMID: 12371804 [PubMed - indexed for MEDLINE]Related articlesFree article

Rationale for and role of thiazolidinediones in type 2 diabetes mellitus.

Lebovitz HE.

Am J Cardiol. 2002 Sep 5;90(5A):34G-41G. Review.PMID: 12231077 [PubMed - indexed for MEDLINE]Related articles

Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction.

Lebovitz HE, Kreider M, Freed MI.

Diabetes Care. 2002 May;25(5):815-21.PMID: 11978674 [PubMed - indexed for MEDLINE]Related articlesFree article

Differentiating members of the thiazolidinedione class: a focus on safety.

Lebovitz HE.

Diabetes Metab Res Rev. 2002 Mar-Apr;18 Suppl 2:S23-9. Review.PMID: 11921435 [PubMed - indexed for MEDLINE]Related articles

Diagnosis, classification, and pathogenesis of diabetes mellitus.

Lebovitz HE.

J Clin Psychiatry. 2001;62 Suppl 27:5-9; discussion 40-1.PMID: 11806489 [PubMed - indexed for MEDLINE]Related articles

Oral therapies for diabetic hyperglycemia.

Lebovitz HE.

Endocrinol Metab Clin North Am. 2001 Dec;30(4):909-33. Review.PMID: 11727405 [PubMed - indexed for MEDLINE]Related articles

Effect of the postprandial state on nontraditional risk factors.

Lebovitz HE.

Am J Cardiol. 2001 Sep 20;88(6A):20H-5H. Review.PMID: 11576522 [PubMed - indexed for MEDLINE]Related articles

Introduction.

Lebovitz HE.

Am J Cardiol. 2001 Sep 20;88(6A):1H-3H. No abstract available. PMID: 11576518 [PubMed - indexed for MEDLINE]Related articles

Insulin resistance: definition and consequences.

Lebovitz HE.

Exp Clin Endocrinol Diabetes. 2001;109 Suppl 2:S135-48. Review.PMID: 11460565 [PubMed - indexed for MEDLINE]Related articles

Insulin resistance and its treatment by thiazolidinediones.

Lebovitz HE, Banerji MA.

Recent Prog Horm Res. 2001;56:265-94. Review.PMID: 11237217 [PubMed - indexed for MEDLINE]Related articlesFree article

Rosiglitazone monotherapy is effective in patients with type 2 diabetes.

Lebovitz HE, Dole JF, Patwardhan R, Rappaport EB, Freed MI; Rosiglitazone Clinical Trials Study Group.

J Clin Endocrinol Metab. 2001 Jan;86(1):280-8. Erratum in: J Clin Endocrinol Metab 2001 Apr;86(4):1659. J Clin Endocrinol Metab. 2002 Feb;2(1):iv.. PMID: 11232013 [PubMed - indexed for MEDLINE]Related articlesFree article

Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus.

Fujioka K, Seaton TB, Rowe E, Jelinek CA, Raskin P, Lebovitz HE, Weinstein SP; Sibutramine/Diabetes Clinical Study Group.

Diabetes Obes Metab. 2000 Jun;2(3):175-87.PMID: 11220553 [PubMed - indexed for MEDLINE]Related articles

Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function.

McFarlane SI, Chaiken RL, Hirsch S, Harrington P, Lebovitz HE, Banerji MA.

Diabet Med. 2001 Jan;18(1):10-6.PMID: 11168335 [PubMed - indexed for MEDLINE]Related articles

Type 2 diabetes: an overview.

Lebovitz HE.

Clin Chem. 1999 Aug;45(8 Pt 2):1339-45. Review.PMID: 10430816 [PubMed - indexed for MEDLINE]Related articlesFree article

Repaglinide versus glyburide: a one-year comparison trial.

Marbury T, Huang WC, Strange P, Lebovitz H.

Diabetes Res Clin Pract. 1999 Mar;43(3):155-66.PMID: 10369424 [PubMed - indexed for MEDLINE]Related articles

Effects of oral antihyperglycemic agents in modifying macrovascular risk factors in type 2 diabetes.

Lebovitz HE.

Diabetes Care. 1999 Apr;22 Suppl 3:C41-4. Review.PMID: 10189561 [PubMed - indexed for MEDLINE]Related articles

Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men.

Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE.

J Clin Endocrinol Metab. 1999 Jan;84(1):137-44.PMID: 9920074 [PubMed - indexed for MEDLINE]Related articlesFree article

Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data.

Chaiken RL, Eckert-Norton M, Bard M, Banerji MA, Palmisano J, Sachimechi I, Lebovitz HE.

Diabetes Care. 1998 Dec;21(12):2129-34.PMID: 9839105 [PubMed - indexed for MEDLINE]Related articlesFree article

Postprandial hyperglycaemic state: importance and consequences.

Lebovitz HE.

Diabetes Res Clin Pract. 1998 Jul;40 Suppl:S27-8. Review. No abstract available. PMID: 9740499 [PubMed - indexed for MEDLINE]Related articles

Advantages of alpha-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients.

Johnston PS, Lebovitz HE, Coniff RF, Simonson DC, Raskin P, Munera CL.

J Clin Endocrinol Metab. 1998 May;83(5):1515-22.PMID: 9589648 [PubMed - indexed for MEDLINE]Related articlesFree article

alpha-Glucosidase inhibitors.

Lebovitz HE.

Endocrinol Metab Clin North Am. 1997 Sep;26(3):539-51. Review.PMID: 9314014 [PubMed - indexed for MEDLINE]Related articles

Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects.

Banerji MA, Lebowitz J, Chaiken RL, Gordon D, Kral JG, Lebovitz HE.

Am J Physiol. 1997 Aug;273(2 Pt 1):E425-32.PMID: 9277397 [PubMed - indexed for MEDLINE]Related articles

Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects.

Chaiken RL, Khawaja R, Bard M, Eckert-Norton M, Banerji MA, Lebovitz HE.

Diabetes Care. 1997 May;20(5):709-13.PMID: 9135931 [PubMed - indexed for MEDLINE]Related articles

Insulin allergy and insulin resistance.

Lebovitz HE.

Curr Ther Endocrinol Metab. 1997;6:500-4. Review. No abstract available. PMID: 9174796 [PubMed - indexed for MEDLINE]Related articles

Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis.

Brunicardi FC, Chaiken RL, Ryan AS, Seymour NE, Hoffmann JA, Lebovitz HE, Chance RE, Gingerich RL, Andersen DK, Elahi D.

J Clin Endocrinol Metab. 1996 Oct;81(10):3566-72.PMID: 8855802 [PubMed - indexed for MEDLINE]Related articles

Long-term normoglycemic remission in black newly diagnosed NIDDM subjects.

Banerji MA, Chaiken RL, Lebovitz HE.

Diabetes. 1996 Mar;45(3):337-41.PMID: 8593939 [PubMed - indexed for MEDLINE]Related articles

Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM.

Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE, Kral JG.

Int J Obes Relat Metab Disord. 1995 Dec;19(12):846-50.PMID: 8963350 [PubMed - indexed for MEDLINE]Related articles

Metabolic effects of darglitazone, an insulin sensitizer, in NIDDM subjects.

Chaiken RL, Eckert-Norton M, Pasmantier R, Boden G, Ryan I, Gelfand RA, Lebovitz HE.

Diabetologia. 1995 Nov;38(11):1307-12.PMID: 8582540 [PubMed - indexed for MEDLINE]Related articles

Interaction of hypertension and diabetes on renal function in black NIDDM subjects.

Chaiken RL, Palmisano J, Norton ME, Banerji MA, Bard M, Sachimechi I, Behzadi H, Lebovitz HE.

Kidney Int. 1995 Jun;47(6):1697-702.PMID: 7643539 [PubMed - indexed for MEDLINE]Related articles

Prolongation of near-normoglycemic remission in black NIDDM subjects with chronic low-dose sulfonylurea treatment.

Banerji MA, Chaiken RL, Lebovitz HE.

Diabetes. 1995 Apr;44(4):466-70.PMID: 7698517 [PubMed - indexed for MEDLINE]Related articles

Diabetic ketoacidosis.

Lebovitz HE.

Lancet. 1995 Mar 25;345(8952):767-72. Review. No abstract available. PMID: 7891491 [PubMed - indexed for MEDLINE]Related articles